Cargando…

Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia

BACKGROUND: Immunohistochemical quantification of the immune response is prognostic for colorectal cancer (CRC). Here, we evaluate the suitability of alternative immune classifiers on prognosis and assess whether they relate to biological features amenable to targeted therapy. METHODS: Overall survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craig, Stephanie G., Humphries, Matthew P., Alderdice, Matthew, Bingham, Victoria, Richman, Susan D., Loughrey, Maurice B., Coleman, Helen G., Viratham-Pulsawatdi, Amelie, McCombe, Kris, Murray, Graeme I., Blake, Andrew, Domingo, Enric, Robineau, James, Brown, Louise, Fisher, David, Seymour, Matthew T., Quirke, Phil, Bankhead, Peter, McQuaid, Stephen, Lawler, Mark, McArt, Darragh G., Maughan, Tim S., James, Jacqueline A., Salto-Tellez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555485/ https://www.ncbi.nlm.nih.gov/pubmed/32684627 http://dx.doi.org/10.1038/s41416-020-0985-5

Ejemplares similares

A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment
por: Viratham Pulsawatdi, Amélie, et al.
Publicado: (2020)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Craig, Stephanie G., et al.
Publicado: (2021)

HistoClean: Open-source software for histological image pre-processing and augmentation to improve development of robust convolutional neural networks
por: McCombe, Kris D., et al.
Publicado: (2021)

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
por: Dunne, Philip D., et al.
Publicado: (2018)

QuPath: Open source software for digital pathology image analysis
por: Bankhead, Peter, et al.
Publicado: (2017)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization
por: Humphries, Matthew P., et al.
Publicado: (2020)

PD-L1 Multiplex and Quantitative Image Analysis for Molecular Diagnostics
por: Abdullahi Sidi, Fatima, et al.
Publicado: (2020)

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
por: Dunne, Philip D., et al.
Publicado: (2017)

Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies
por: Alderdice, Matthew, et al.
Publicado: (2018)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis
por: Sidi, Fatima Abdullahi, et al.
Publicado: (2023)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Automated tumor analysis for molecular profiling in lung cancer
por: Hamilton, Peter W., et al.
Publicado: (2015)

Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities
por: Humphries, Matthew P., et al.
Publicado: (2019)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
por: Humphries, Matthew P., et al.
Publicado: (2020)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study
por: Gray, Ronan T, et al.
Publicado: (2017)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
por: Wilkinson, Richard D. A., et al.
Publicado: (2019)

Identification of a prognostic signature in colorectal cancer using combinatorial algorithm‐driven analysis
por: Alnabulsi, Abdo, et al.
Publicado: (2022)

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies
por: Alvi, Muhammad A, et al.
Publicado: (2017)

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
por: Gray, Ronan T, et al.
Publicado: (2017)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer
por: Elkashif, Ahmed, et al.
Publicado: (2020)

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study
por: McCain, Stephen, et al.
Publicado: (2018)

Technical note on the exploration of COVID-19 in autopsy material
por: Humphries, Matthew Phillip, et al.
Publicado: (2023)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lioq4af5kc7392e4vih2fhb0gk